Where the hidden margin sits, in every portfolio company.
A rapid profitability diagnostic across your participadas: one Health Check and one whale curve per company, built from their own ERP and operational exports, consolidated at fund level. In weeks, not quarters, and without a consulting army inside each company.
One margin map per company. One view for the fund.
Per participada: Health Check + whale curve
Each company's customers and products ranked by real net margin, with the loss-making tail identified and quantified from their own data.
Fund-level consolidation
The portfolio on one page: which companies hide the most recoverable margin, ranked by the size of the prize, with a read-out per company.
A prioritised action list
For each company, the two or three levers that recover margin fastest: re-pricing, minimum order values, service-level changes. With the euro sizes attached, privately.
Weeks, not quarters.
Scoping call
Portfolio shape, data availability, and which companies go first.
One export per company
ERP or financial and operational exports. No system installs, no disruption.
Model and verify
We build the cost-to-serve model per company and verify the tails with each CFO.
Fund read-out
The consolidated view and the per-company action lists, presented to the deal team.
Scoped by proposal, per participada.
The number depends on each company's data and complexity, so we scope it openly in days and profiles, and put the figure in a written proposal after the scoping call.
What funds ask us.
How is this different from commissioning a diagnostic per company?
What do the portfolio companies have to do?
Can it run pre-acquisition, on a target?
What happens after the scan?
Why no public price?
See one whale curve, then decide.
The Free Profit Check runs on a single company, from one export. It is the cheapest way to see whether the portfolio scan will pay for itself.